New Light-Sensing Biometric Sensor Aids in Efficient Early Cancer Diagnosis

A research team from the Korea Institute of Materials Science (KIMS) has developed a novel optical biosensor capable of efficiently detecting trace amounts of cancer cell DNA in the blood, aiding in early cancer diagnosis. This sensor utilizes optical signals and artificial intelligence (AI) to directly identify methylated DNA, bypassing the complex processing steps typically required for traditional liquid biopsies. Compared to existing technologies, this new biosensor demonstrates significantly enhanced sensitivity and specificity, enabling more accurate detection of early-stage cancer signals. The breakthrough simplifies the diagnostic process, offering a rapid, non-invasive screening method for clinical settings. This advancement has the potential to facilitate broader adoption of early cancer diagnosis techniques, ultimately improving patient outcomes. For more details, refer to the published study at this link.